William J Tanski
Overview
Explore the profile of William J Tanski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beck A, Nolan B, De Martino R, Yuo T, Tanski W, Walsh D, et al.
J Vasc Surg
. 2009 Nov;
51(2):380-5.
PMID: 19939607
Background: Although technical success of renal artery stenting (RAS) is high and adverse events are infrequent, clinical success (improved blood pressure and renal function) and durability have been less predictable....
2.
Galaria I, Surowiec S, Tanski W, Fegley A, Rhodes J, Illig K, et al.
Vasc Endovascular Surg
. 2005 Sep;
39(5):393-400.
PMID: 16193211
Modern therapy, including endoluminal procedures and improved medical management, still yield less than desired results for tibial vessel occlusive disease. Despite the recent focus on these newer interventions, few modern...
3.
Tanski W, Nicholl S, Kim D, Fegley A, Roztocil E, Davies M
J Vasc Surg
. 2005 Feb;
41(1):91-8.
PMID: 15696050
Background: Vascular smooth muscle cell (SMC) migration is an important component of the development of intimal hyperplasia. Sphingosine-1-phosphate (S-1-P) is a lipid released from activated platelets with numerous cellular effects...
4.
Surowiec S, Fegley A, Tanski W, Sivamurthy N, Illig K, Lee D, et al.
Vasc Endovascular Surg
. 2004 Aug;
38(4):349-54.
PMID: 15306953
The purpose of this study was to determine the functional results of transvenous angioplasty for the treatment of central venous stenoses in patients with failing upper extremity arteriovenous access. Two...
5.
Surowiec S, Davies M, Fegley A, Tanski W, Pamoukian V, Sternbach Y, et al.
J Vasc Surg
. 2004 Apr;
39(4):804-10.
PMID: 15071446
Objectives: This study was performed to determine whether there is deterioration in renal function during follow-up in patients who have undergone endovascular aneurysm repair (EVAR), as recommended by the device...
6.
Tanski W, Fegley A, Roztocil E, Davies M
J Vasc Surg
. 2004 Jan;
39(1):214-22.
PMID: 14718842
Background: Single-chain urokinase-type plasminogen activator (sc-uPA) is one of the key serine proteases involved in modulating cellular and extracellular matrix responses during tissue remodeling. Sc-uPA is composed of three domains:...
7.
Fegley A, Tanski W, Roztocil E, Davies M
J Surg Res
. 2003 Aug;
113(1):32-41.
PMID: 12943808
Background: Sphingosine-1-phosphate (S-1-P) is an extracellular mediator released in response to vessel injury. S-1-P binds to G-protein-coupled receptors, which can be Galpha(i)-, Galpha(q)-, or G(12/13)-linked. This study examines the role...